🔎 Trials Near Me

Hem › Steatotisk leversjukdom › Florida › Miami

Kliniska studier för Steatotisk leversjukdom i Miami, FL

16 studier för Steatotisk leversjukdom söker deltagare vid platser i och runt Miami (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

RekryterarFas 3
  • 89bio Clinical Study Site, Miami
  • 89bio Clinical Study Site, Miami
  • 89bio Clinical Study Site, Miami
Ålder 18 till 75 · Alla kön · Uppdaterad 5 okt. 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

RekryterarFas 3
  • 89bio Clinical Study Site, Miami
Ålder 18 till 80 · Alla kön · Uppdaterad 5 okt. 2026 · NCT06318169

A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

RekryterarFas 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
Ålder 18 till 75 · Alla kön · Uppdaterad 30 sep. 2026 · NCT07704892

A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

RekryterarFas 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
Ålder 18 till 75 · Alla kön · Uppdaterad 30 sep. 2026 · NCT07701993

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

RekryterarFas 2
  • Evolution Clinical Trials, Miami
Ålder 18 till 75 · Alla kön · Uppdaterad 29 sep. 2026 · NCT07527910

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

RekryterarFas 2
  • University of Miami Health System, Miami
Ålder 18 till 75 · Alla kön · Uppdaterad 28 sep. 2026 · NCT05832229

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

RekryterarFas 2
  • Genoma Research Group, Inc., Miami
  • Med Research of Florida, LLC, Miami
Ålder 18 till 75 · Alla kön · Uppdaterad 25 sep. 2026 · NCT05519475

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

RekryterarFas 3
  • Evolution Clinical Trials, Miami
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

RekryterarFas 3
  • Akero Clinical Study Site, Miami
  • Akero Clinical Study Site, Miami
Ålder 18 till 80 · Alla kön · Uppdaterad 21 sep. 2026 · NCT06528314

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

RekryterarFas 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • och 3 fler
Ålder 18 till 75 · Alla kön · Uppdaterad 17 sep. 2026 · NCT07221188

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

RekryterarFas 2
  • GSK Investigational Site, Miami
Ålder 18 till 70 · Alla kön · Uppdaterad 3 aug. 2026 · NCT06613698

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

RekryterarFas 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • och 4 fler
Ålder 18 till 75 · Alla kön · Uppdaterad 27 juli 2026 · NCT07221227

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

RekryterarFas 2
  • GSK Investigational Site, Miami
Ålder 18 till 75 · Alla kön · Uppdaterad 8 juli 2026 · NCT06920043

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

RekryterarFas 1/2Friska volontärer välkomna
  • Genoma Research Group, Inc, Miami
  • Med Research of Florida, LLC, Miami
Ålder 18 till 75 · Alla kön · Uppdaterad 16 apr. 2026 · NCT05648214

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

RekryterarObservationsstudie
  • Clinical Pharmacology of Miami, Miami
Ålder 18 till 75 · Alla kön · Uppdaterad 14 aug. 2025 · NCT07122700

Steatotisk leversjukdom-studier i andra städer

Andra studier i Miami

Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.